Aligos Therapeutics Appoints David Perry as Vice President of Business Development
Aligos Therapeutics (Nasdaq: ALGS) has appointed David Perry as Vice President of Business Development, effective...
Aligos Therapeutics (Nasdaq: ALGS) has appointed David Perry as Vice President of Business Development, effective...